- Eric Chaffin | May 29, 2012 5:29 PM | New York, NY
Category:
FDA & Prescription Drugs
On June 15, 2011, the FDA released a safety announcement warning the public and healthcare professionals that long-term use of the diabetes drug Actos may increase the risk of bladder cancer. The...
- Paul Napoli | June 10, 2011 11:41 PM | New York City, NY
Category:
FDA & Prescription Drugs
June 10, 2011
Regulators in France and Germany yesterday pulled Actos (pioglitazone), the most widely used medication for the treatment of type 2 diabetes, off the market after a study sponsored by...
- Paul Napoli | September 18, 2010 12:19 AM | New York City, NY
Category:
FDA & Prescription Drugs
September 17, 2010
The U.S. Food and Drug Administration (FDA) announced today that the agency is reviewing data from an ongoing 10-year study to evaluate whether Actos (pioglitazone) is associated...